Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020440 (
hypercapnia
)
7,939
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Progesterone administration increase VE in man, but its effects on ventilatory response to
hypercapnia
and hypoxia have not been well documented. Accordingly, VE, HVR, and HCVR were measured during placebo and
MPA
administration in 11 normal men. The effect of
MPA
(20 mg orally q 8 hr for 32 hr) on T degrees, metabolic rate (VO2 and VCO2) was also determined. With
MPA
, T degrees, rose 0.4 degrees C +/- 0.0008 (S.E.M.) p less than 0.0001), VE increased 0.46 +/- 0.16 L/min (p less than 0.01), and VO2 and VCO2 did not change significantly. HCVR (measured under hyperoxic conditions during rebreathing) increased significantly (P less than 0.01) from 2.9 +/- 0.33 L/min/mm Hg (placebo) to 4.0 +/- 0.29 (
MPA
). HVR was measured as the shape parameter A, so that when A increased, HVR was augmented. During
MPA
, HVR increased from A = 132 +/- 19.1 to 179 +/- 20.5 (P less than 0.02). We conclude that 60 mg of
MPA
daily in normal men increases VE and chemosensitivity as measured by the ventilatory response to
hypercapnia
and hypoxia.
...
PMID:Effects of progesterone on chemosensitivity in normal men. 35 85